MedPath
FDA Product

ADVAIR DISKUS

Product approved by U.S. Food and Drug Administration (US)

Basic Information

ADVAIR DISKUS

54868-4516

Regulatory Information

54868-4516

NDA021077

C73594

November 12, 2010

USA

These highlights do not include all the information needed to use ADVAIR DISKUS safely and effectively. See full prescribing information for ADVAIR DISKUS.ADVAIR DISKUS 100/50(fluticasone propionate 100 mcg and salmeterol 50 mcg inhalation powder)ADVAIR DISKUS 250/50(fluticasone propionate 250 mcg and salmeterol 50 mcg inhalation powder)ADVAIR DISKUS 500/50(fluticasone propionate 500 mcg and salmeterol 50 mcg inhalation powder)FOR ORAL INHALATIONInitial U.S. Approval: 2000

HUMAN PRESCRIPTION DRUG LABEL

1

Company Information

194123980

Active Ingredients

SALMETEROL XINAFOATE

Quantity: 50 ug in 1 1

Code: 6EW8Q962A5

Class Code: ACTIB

FLUTICASONE PROPIONATE

Quantity: 500 ug in 1 1

Code: O2GMZ0LF5W

Class Code: ACTIB

Inactive Ingredients

LACTOSE

Code: J2B2A4N98G

Class Code: IACT

Active Moieties

FLUTICASONE

Code: CUT2W21N7U

SALMETEROL

Code: 2I4BC502BT

© Copyright 2025. All Rights Reserved by MedPath